Advertisement
Organisation › Details
Paion Inc.
Start | 2014-10-01 established | |
Group | Humanwell Healthcare (Group) | |
Industry | remimazolam (CNS 7056) | |
Person | Papaz, Greg (Paion 201410– CEO of Paion Inc before Optimer Pharmaceuticals + Roche + Sanofi) | |
Person 2 | Söhngen, Wolfgang (Paion 200603 CEO) | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Record changed: 2023-12-23 |
Advertisement
More documents for Humanwell Healthcare (Group)
- [1] Paion AG. (12/22/23). "Press Release: Sale of the Business Operations". Aachen....
- [2] Paion AG. (10/26/23). "Press Release: Filing an Application for the Opening of Insolvency Proceedings [ad hoc]". Aachen....
- [3] Paion AG. (7/2/20). "Press Release: Paion Announces U.S. FDA Approval of Remimazolam (Byfavo) for the Induction and Maintenance of Procedural Sedation". Aachen....
- [4] Metrion Biosciences Ltd.. (4/8/19). "Press Release: Metrion Biosciences Appoints Dr Andrew Southan as Chief Executive Officer". Cambridge....
- [5] Paion AG. (12/6/17). "Press Release: Jürgen Beck, MD, Appointed as Chief Development Officer at Paion AG". Aachen....
- [6] Paion AG. (3/9/17). "Press Release: Change in the Management Board". Aachen....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top